Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-16-000946
Filing Date
2016-12-14
Accepted
2016-12-14 16:59:04
Documents
42
Period of Report
2016-08-31

Document Format Files

Seq Description Document Type Size
1 10-K sibannac_10k-083116.htm 10-K 432165
2 CERTIFICATION sibannac_10k-ex3101.htm EX-31.1 6723
3 CERTIFICATION sibannac_10k-ex3102.htm EX-31.2 6835
4 CERTIFICATION sibannac_10k-ex3201.htm EX-32.1 3765
5 CERTIFICATION sibannac_10k-ex3202.htm EX-32.2 3842
6 GRAPHIC image_001.jpg GRAPHIC 22897
7 GRAPHIC image_002.jpg GRAPHIC 18082
  Complete submission text file 0001683168-16-000946.txt   1507908

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE snnc-20160831.xml EX-101.INS 126082
9 XBRL SCHEMA FILE snnc-20160831.xsd EX-101.SCH 15100
10 XBRL CALCULATION FILE snnc-20160831_cal.xml EX-101.CAL 30499
11 XBRL DEFINITION FILE snnc-20160831_def.xml EX-101.DEF 33673
12 XBRL LABEL FILE snnc-20160831_lab.xml EX-101.LAB 121953
13 XBRL PRESENTATION FILE snnc-20160831_pre.xml EX-101.PRE 94170
Mailing Address 1313 E. OSBORN PHOENIX AZ 85014
Business Address 1313 E. OSBORN PHOENIX AZ 85014 480-420-3171
Sibannac, Inc. (Filer) CIK: 0001313938 (see all company filings)

EIN.: 330903494 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-55578 | Film No.: 162051639
SIC: 2834 Pharmaceutical Preparations